TOLLIP

Across TCGA pan-cancer cohorts, TOLLIP Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated TOLLIP data layer compared with 26 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher TOLLIP Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TOLLIP expression acts as an unfavorable survival marker, although some lineages such as SKCM and UCEC show a favorable association.

COAD, LIHC, and SKCM are the cancer types where TOLLIP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	II,III,IV	0.191	0.666	<.001	16	view →
LIHC	OS	Median	All	0.061	0.783	<.001	12	view →
SKCM	OS	Median	All	1.000	0.327	.013	4	view →
UCEC	DFS	Median	All	0.957	0.623	.040	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

TOLLIP–COAD (DFS)

Open the COAD breakdown →